Home › Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate
 

Keywords :   


Immuron begins patient recruitment for Phase 2 clinical trial of IMM-124E NASH drug candidate

2015-02-03 14:17:18| Agriculture - Topix.net

Australian biopharmaceutical company Immuron Limited has today announced a significant milestone in its Phase 2 clinical trial for non-alcoholic steatohepatitis with the recruitment of its first two patients at Duke University in the United States. It is expected that further recruitment at Duke and other sites in the US and Australia will follow in early course.

Tags: trial drug phase patient

Category:Agriculture and Forestry

Latest from this category

All news
05.11Delayed implementation of EID eartag rule requested
05.11Why forage is the cornerstone of a working ranch horses diet
05.11American Angus elects 2024-25 board leaders
05.11Brazil gives green light to medicinal use of Cannabis in animals
05.11Farmer sentiment in October rebounds ahead of the U.S. election
05.11We might not like it, but overhead must be evaluated
05.11Phibro Animal Health completes acquisition of Zoetis medicated feed additive portfolio
05.11November/December 2024 Digital Edition of National Hog Farmer now available
Agriculture and Forestry »
06.11Hurricane Rafael Update Statement
06.11Summary for Hurricane Rafael (AT3/AL182024)
06.11Warning millions will struggle to pay water bill rises
06.11Atlantic Tropical Weather Outlook
06.11Tropical Storm Rafael Graphics
06.11Tropical Storm Rafael Public Advisory Number 9A
06.11Summary for Tropical Storm Rafael (AT3/AL182024)
06.11Eastern North Pacific Tropical Weather Outlook
More »